In The Press

Home/In The Press
In The Press2017-10-18T01:32:10+00:00
1101, 2021

Phyton Biotech Announces the Successful Establishment of Plant Cell Lines to Source Key Building Block for Treatment of Rare Dermatologic Conditions

January 11th, 2021|

Phyton Biotech’s Plant Cell Fermentation (PCF) technology has been successfully used to develop high-yielding plant cell lines of the source of cyclopamine, a key raw material for PellePharm’s patedigib topical gel.

1804, 2019

AqVida and Phyton Biotech Receive Approval from European Directorate of Quality Medicines for AqVida’s Cancer-fighting Paclitaxel Injectable Finished Dosage Formulation

April 18th, 2019|

AqVida and Phyton Biotech Receive Approval from European Directorate of Quality Medicines.

Go to Top